透過您的圖書館登入
IP:3.128.79.107
  • 期刊

臺灣地區省產礦物性中藥之可適性研究

Feasibility Study of Minerals for Use as Chinese Medicine In Taiwan

摘要


本研究以台灣地區10種市售礦物性中藥材和省產礦物類進行礦物鑑定與微量元素分析,並做一比較,其結果有六種市售礦物性中藥材名稱與礦物學名不符,省產黃鐵礦、高嶺土與市售之寒水石、白石英皆超過規定鉛含量30ppm之標準,省產黃鐵礦與石灰之鎘含量超過規定2ppm標準,省產黃鐵礦汞含量超過規定標準2ppm。依分析結果,省產礦物中,黃鐵礦、高嶺土與石灰不適合取代市售中藥礦物,而市售中藥性礦物之寒水石與白石英則有鉛含量過高之現象。

關鍵字

中藥 礦物 重金屬

並列摘要


Chinese medicine was known as old as chinese history. In Taiwan, people have already paid attention to the importance of Chinese drugs for quite a long time. Most of Chinese medicine can be made of and extracted from natural plants, animals and minerals. The lesser but important use of mineral ingredient in drugs has been already known in Asian areas, especially Mainland China. So the purpose of this study is to preliminary understand the mineral species and its accepted content of medical ingredients from minerals or materials both in Chinese medicine market and Taiwan mineral deposits. The key results of the present study show that Pb content from pyrite and kaolinite ingredients in Taiwan mineral deposits are 133.1 ppm and 40.63ppm respectively, which are somewhat higher than 30ppm in medical ingredients regulated by the government. Meanwhile, Pb contents in Hanshuishi and Baishilying samples collected from domestic Chinese drugstore are also a little higher than the figure of accepted limit. In addition, Cd contents of pyrite and calcined lime from mineral deposit in Taiwan. a little exceed the 2ppm permit limits. Pyrite from mineral deposits contains 98.87ppm of Hg which is extremely higher than 2ppm maximum permitted concentration. In conclusion, both pyrite、kaolinite and calcined lime from mineral deposits in Taiwan are not suitable for use as mineral ingredient in drugs.

並列關鍵字

Chinese medicine Mineral Heavy Metal

延伸閱讀